Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Enigma Diagnostics, a point-of-care molecular diagnostics company, has signed a third licensing agreement with Applied Biosystems.
Subscribe to our email newsletter
The license provides Enigma with access to claims of US patent that describe methods for monitoring nucleic acid amplification in real-time. This is the first such license Applied Biosystems has granted to the method claims of the patent.
This is said to complement Enigma’s existing license under certain patents owned by Applied Biosystems for real-time polymerase chain reaction thermal cyclers.